Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

8601	Companies
140631	Keywords
76564	Articles
75122	Press releases

Home
Companies
Moderna, Inc.

BRIEF

published on 02/25/2025 at 13:05, 1 month 10 days ago

Moderna to Participate in March 2025 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna
PRESS RELEASE

published on 02/25/2025 at 13:00, 1 month 10 days ago

Moderna to Present at Upcoming Conferences in March 2025
Moderna, Inc. to participate in investor conferences. Live webcasts available. Leading in mRNA medicine, advancing technology for disease treatment/prevention

Investor Conferences Healthcare COVID-19 Vaccine MRNA Medicine Moderna
BRIEF

published on 02/14/2025 at 12:33, 1 month 21 days ago

Moderna Announces 2024 Financial Results and Future Projections

Cost Reduction Moderna Revenue Projections Financial Results 2024 MRNA Products
BRIEF

published on 02/14/2025 at 12:33, 1 month 21 days ago

Moderna annonce ses résultats financiers pour 2024 et ses projections futures

Réduction Des Coûts Projections De Revenus Moderne Résultats Financiers 2024 Produits D'ARNm
PRESS RELEASE

published on 02/14/2025 at 12:28, 1 month 21 days ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 2 months 9 days ago

Moderna annoncera ses résultats financiers pour le quatrième trimestre et 2024

Résultats Financiers Webcast Mise À Jour De L'entreprise Moderne Technologie De L'ARNm
BRIEF

published on 01/29/2025 at 13:05, 2 months 9 days ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 2 months 9 days ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 2 months 14 days ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
BRIEF

published on 01/24/2025 at 12:35, 2 months 14 days ago

Moderna remporte un appel d'offres européen pour l'approvisionnement en vaccins à ARNm contre la COVID-19

Moderne COVID 19 Vaccin À ARNm Spikevax Appel D'offres De L'UE

Accesswire

Published on 04/07/2025 at 14:30, 13 minutes ago

Newsmax Enters into Standby Equity Purchase Agreement of Up to $1.2 Billion With Yorkville Advisors
Published on 04/07/2025 at 14:30, 13 minutes ago

Sparta Provides Update on Delay in Filing Annual Financial Statements
Published on 04/07/2025 at 14:00, 43 minutes ago

NOA Lithium Advances Towards 2025 Water Exploration at Rio Grande Project
Published on 04/07/2025 at 14:00, 43 minutes ago

Rio Grande Resources Announces the Successful Completion of Sampling and Field Campaign at the Winston Gold-Silver Project
Published on 04/07/2025 at 14:00, 43 minutes ago

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

View all ACCESSWIRE

EQS Group

Published on 04/07/2025 at 14:26, 16 minutes ago

Share Buyback
Published on 04/07/2025 at 14:24, 18 minutes ago

OTRS AG: Voluntary Public Tender Offer of Optimus BidCo AG
Published on 04/07/2025 at 13:00, 1 hour 43 minutes ago

CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
Published on 04/07/2025 at 12:57, 1 hour 45 minutes ago

PFISTERER acquires long-standing partner Power CSL - portfolio expanded to include subsea solutions
Published on 04/07/2025 at 11:57, 2 hours 45 minutes ago

Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014

Les Echos

Published on 04/07/2025 at 07:01, 7 hours 42 minutes ago

bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques
Published on 04/07/2025 at 07:01, 7 hours 42 minutes ago

bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
Published on 04/04/2025 at 19:18, 2 days 19 hours ago

Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 19 hours ago

Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 20 hours ago

Reporting on share buyback transactions carried out between March 31 and April 3, 2025

View all LES ECHOS COMFI WIRE